We conducted this retrospective study to document the efficacy and safety,
and demonstrate the spectrum of indications for subcutaneously tunneled epi
dural catheters in the management of prolonged pain in pediatric patients.
The charts of 25 patients with prolonged pain that was unresponsive to conv
entional opioid therapy (10: end stage malignancy 8 extensive abdominal sur
gery, 7: trauma, etc.) and who received thoracic, lumbar, or caudal tunnele
d epidural catheters between 1995 and 1999 were reviewed for efficacy and c
atheter related complications (infection or bleeding at the insertion site,
toxicity related to local anesthetics, tachyphylaxis and respiratory depre
ssion). Tunneled epidural catheters were effective in providing extended an
algesia in all subjects. In 14 patients with chronic pain, cumulative 48-h
enteral and parenteral opioid requirements were reduced or eliminated after
catheter insertion. Catheters remained in place for a median of 11 days (r
ange, 4-240 days) until there was no further need for parenteral analgesia
(n = 15), death because of the underlying disease (n = 6), accidental remov
al (n = 2), or possible infection (n = 2). No serious local or systemic com
plications (meningitis, epidural abscess, systemic infection, epidural hema
toma, or spinal cord injury; seizures, local anesthetic toxicity) occurred
related to this technique. Five patients were discharged from the hospital
with the catheter for home analgesic therapy. The use of a percutaneously i
nserted, subcutaneously tunneled epidural catheter is safe, effective, and
provides pain relief in situations in which conventional analgesic therapy
Either fails or is impractical. The technique is one that may be of great v
alue to children suffering from pain.